Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disease in Canines

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Business Wire (English), 06/22/2022